Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia research)

Journal of Nutrition, Health and Aging

Volumn 15, Issue 10, 2011, Pages 834-846

  Abellan Van Kan, G ^a   Cedarbaum, J M ^b   Cesari, M ^a   Dahinden, P ^c   Fariello, R G ^c   Fielding, R A ^d   Goodpaster, B H ^e   Hettwer, S ^c   Isaac, M ^f   Laurent, D ^g   Morley, J E ^h   Pahor, M ⁱ   Rooks, D ^j   Roubenoff, R ^j   Rutkove, S B ^k   Shaheen, A ^c   Vamvakas, S ^f   Vrijbloed, J W ^c   Vellas, B ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Cytokinetics Inc   (United States)

^c NEUROTUNE AG   (Switzerland)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f EUROPEAN MEDICINES AGENCY   (United Kingdom)

^g NOVARTIS PHARMA AG   (Switzerland)

^h SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j Biogen Idec   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Amyotrophic Lateral Sclerosis; Appendicular Skeletal Muscle Mass; CHMP; Muscle Mass; Nutr Health Aging

Indexed keywords

AGRIN; BIOLOGICAL MARKER;

AGING; ARTICLE; BLOOD; BODY COMPOSITION; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; MUSCLE ATROPHY; MUSCLE STRENGTH; MUSCLE WEAKNESS; NOMENCLATURE; ORGANIZATION; PATHOLOGY; SKELETAL MUSCLE;

AGING; AGRIN; BIOLOGICAL MARKERS; BODY COMPOSITION; CONGRESSES AS TOPIC; DIAGNOSTIC IMAGING; HUMANS; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; SARCOPENIA; TERMINOLOGY AS TOPIC;

MLCS; MLOWN;

EID: 84861810609     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0365-1     Document Type: Conference Paper

References (12)

1. Onder, G., Della Vedova, C., Landi, F., Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 13:8 (2009), 746–756 PubMed PMID: 19657562 10.1007/s12603-009-0209-4.
2. Rolland, Y., Pillard, F., Validated treatments and therapeutic perspectives regarding physical activities. J Nutr Health Aging 13:8 (2009), 742–745 PubMed PMID: 19657561 10.1007/s12603-009-0208-5.
3. Bischoff Ferrari, H.A., Validated treatments and therapeutic perspectives regarding nutritherapy. J Nutr Health Aging 13:8 (2009), 737–741 PubMed PMID: 19657560 10.1007/s12603-009-0207-6.
4. Studenski, S., What are the outcomes of treatment among patients with sarcopenia?. J Nutr Health Aging 13:8 (2009), 733–736 PubMed PMID: 19657559 10.1007/s12603-009-0206-7.
5. Studenski, S., Target population for clinical trials. J Nutr Health Aging 13:8 (2009), 729–732 PubMed PMID: 19657558 10.1007/s12603-009-0205-8.
6. Pahor, M., Manini, T., Cesari, M., Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 13:8 (2009), 724–728 PubMed PMID: 19657557 10.1007/s12603-009-0204-9.
7. Visser, M., Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 13:8 (2009), 713–716 PubMed PMID: 19657555 10.1007/s12603-009-0202-y.
8. Abellan van Kan, G., Epidemiology and consequences of sarcopenia. J Nutr Health Aging 13:8 (2009), 708–712 PubMed PMID: 19657554 10.1007/s12603-009-0201-z.
9. Abellan van Kan, G., André, E., Bischoff Ferrari, H.A., Boirie, Y., Onder, G., Pahor, M., Ritz, P., Rolland, Y., Sampaio, C., Studenski, S., Visser, M., Vellas, B., Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging 13:8 (2009), 700–707 PubMed PMID: 19657553 10.1007/s12603-009-0200-0.
10. Fielding, R.A., Vellas, B., Evans, W.J., Bhasin, S., Morley, J.E., Newman, A.B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., Cederholm, T., Chandler, J., De Meynard, C., Donini, L., Harris, T., Kannt, A., Keime Guibert, F., Onder, G., Papanicolaou, D., Rolland, Y., Rooks, D., Sieber, C., Souhami, E., Verlaan, S., Zamboni, M., Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:4 (2011), 249–256 PubMed PMID: 21527165 10.1016/j.jamda.2011.01.003.
11. Chumlea, W.C., Cesarit, M., Evans, W.J., Ferrucci, L., Fielding, R.A., Pahor, M., Studenski, S., Vellas, B., Task Force Members, International working group on sarcopenia. J Nutr Health Aging 15:6 (2011), 450–4505 PubMed PMID: 21623466 10.1007/s12603-011-0092-7.
12. Boirie, Y., Physiopathological mechanism of sarcopenia. J Nutr Health Aging 13:8 (2009), 717–723 PubMed PMID: 19657556 10.1007/s12603-009-0203-x.